COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP36...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -1.9x | ||
| Revenue | - | ||
| Net Income to Company | -155.1 M |
| CMPS | Peers | Sector | |
|---|---|---|---|
Market Cap | 313.2 M | 717.5 M | 64.048 M |
Price % of 52 Week High | 33.2% | 49.0% | 60.4% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -21.2% | -26.6% | -0.7% |
1 Year Price Total Return | -59.6% | -47.5% | -12.3% |
Beta (5 Year) | 2.35 | 1.34 | 0.64 |
| (presentment in thousands) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | |||||
| Operating Income | (0.10) | (0.12) | (0.16) | (0.04) | (0.04) |
| Net Profit | (0.09) | (0.12) | (0.16) | (0.03) | (0.04) |
| Diluted EPS | -2.16 | -2.32 | -2.30 | -0.53 | -0.63 |
| EBITDA | (0.10) | (0.12) | (0.16) | (0.03) | (0.04) |
| Balance Sheet | |||||
| Cash & ST Invest. | 0.14 | 0.22 | 0.17 | 0.22 | 0.17 |
| Current Assets | 0.19 | 0.26 | 0.20 | 0.26 | 0.20 |
| Total Assets | 0.20 | 0.28 | 0.21 | 0.28 | 0.21 |
| Current Liabilities | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
| Total Liabilities | 0.02 | 0.05 | 0.06 | 0.05 | 0.06 |
| Total Equity | 0.18 | 0.23 | 0.15 | 0.23 | 0.15 |
| Total Debt | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (0.11) | (0.10) | (0.12) | (0.03) | (0.04) |
| Cash From Investing | 0.00 | 0.00 | 0.00 | ||
| Cash From Financing | 0.00 | 0.17 | 0.06 | 0.00 | 0.00 |
| Free Cash Flow | (0.11) | (0.10) | (0.12) | (0.03) | (0.04) |